Search Results 1171-1180 of 17020 for monoclonal antibody

1. A Study to Evaluate the Effectiveness and Safety of P276-00 for Mantle Cell Lymphoma that has Returned and/or is Resistant to Treatment - Mayo Clinic

   Prior treatment with monoclonal antibodies or any radio- or toxin- immunoconjugates within 3 months of study drug administration. However rituximab treatment ...

2. A Study to Assess the Effectiveness, Safety and Tolerability of Dupilumab in Patients with Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD) with Type 2 Inflammation - Mayo Clinic

   Exposure to another investigative drug (small molecules as well as monoclonal antibodies) ... The minimum interval since exposure to any other (non-antibody) ...

3. Clinical trials - Oncology (Medical)

   This is a Phase I/II study designed to evaluate if experimental anti-TIGIT/anti-PD-1 bispecific antibody rilvegostomig (AZD2936) is safe, tolerable and ...

4. Ofatumumab as Primary Therapy of Chronic Graft Versus Host Disease - Mayo Clinic

   Prior treatment with anti-CD20 monoclonal antibody or alemtuzumab within 3 months prior to start of therapy. Uncontrolled infectious complications not ...

5. Low-Dose or High-Dose Lenalidomide in Treating Children with Recurrent, Refractory, or Progressive Pilocytic Astrocytoma or Optic Pathway Glioma - Mayo Clinic

   Monoclonal antibodies: at least 3 half-lives of the antibody after the last dose; Radiation therapy (RT): patients must have had their last fraction of ...

6. Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C Melanoma Patients

   Previous in vivo exposure to monoclonal antibodies for biological therapy in the 6 weeks before enrollment. Planned administration of growth factors or ...

7. Multiple myeloma - Doctors and departments - Mayo Clinic

   Learn about this cancer that forms from white blood cells called plasma cells. Treatments include medicines and bone marrow transplant.

8. Phase 2 Efficacy, Safety, and Tolerability Study of Natalizumab in Focal Epilepsy - Mayo Clinic

   ... antibody). Signs of active herpes simplex type 1 or 2 or varicella within 4 ... Exposure to monoclonal antibodies, cytokines, growth factors, soluble ...

9. A Study of the Safety and Effectiveness of Amatuximab in Combination with Pemetrexed and Cisplatin in Subjects with Unremoveable Malignant Pleural Mesothelioma - Mayo Clinic

   ... monoclonal antibody therapy, amatuximab or any of its excipients); Pregnant and/or lactating females are excluded. A negative beta-human chorionic ...

10. Vaccine Therapy Plus Pembrolizumab in Treating Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer (FRAPPE) - Mayo Clinic

    ... monoclonal antibody - Treatment with IV anti-cancer therapy =< 3 weeks prior to registration or with oral anti-cancer therapy =< 1 week prior to ...